How an Unproven Alzheimer’s Drug Got Approved

Posted by on July 19, 2021 7:57 PM
Tags:
Categories: NYT

Though some of its own senior officials said there was little evidence of benefit for patients, the F.D.A. nonetheless greenlighted Biogen’s Aduhelm, or aducanumab.